Allison Inserro

The drive towards value-based care could accelerate through competition among health plans.

A new study comparing triple therapy for chronic obstructive pulmonary disease (COPD) against dual therapy resulted in a lower rate of moderate or severe COPD exacerbations and a lower rate of hospitalizations.

Two different approaches to attack the opioid-fueled substance use disorder (SUD) crisis are on display this week.

Childhood factors predisposed children to lung function decline and chronic obstructive pulmonary disease (COPD) as adults, according to 2 recent studies.

More action is needed to address health disparities, risk factors, and social determinants of health, as well as disease prevention.

CMS tweaked an opioid policy aimed at Medicare Part D patients that drew criticism when it was first released in draft form.

Sanofi plans to offer a discount for some patients with diabetes who are uninsured or who have high-deductible insurance plans.

Commonwealth Fund researchers present ideas for increasing competition, applying value-based purchasing, and protecting patients from high out-of-pocket costs.

Hospital Readmissions Reduction Program established through the Affordable Care Act found to penalize facilities that serve a large number of minority patients.

Condition-specific readmissions measures for heart failure, pneumonia, and heart attack may not accurately or fairly reflect hospital quality.

Medicare Part B and D have different formulary structures and cost sharing.

Only 9% of those with employer coverage are not confident about the future of their health insurance.

Newly-proposed legislation would block the expansion of association health plans.

Last week, the Trump administration proposed extending the time Americans can stay in short-term plans from 3 months to 12 months.

Medicaid was a leading payer for inpatient hospital stays among multiple age groups over a 15-year period.